81,82,83,84,85,86,87 Langlois et al
Science thats preliminary or disputed Science thats preliminary or disputed By the time Noom entered the GLP-1 business in May 2023, both the Eli Lilly and Novo Nordiskfunded studies, which found that most gain back much of the weight they lost after going off the drugs, had been published
Subjects who received liraglutide were also reported to have a higher incidence of arrhythmia vs
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials
sermorelin may increase IGF-1), compounded GI side effects (nausea, vomiting, constipation), potential fluid retention or joint symptoms from elevated growth hormone, and unknown long-term metabolic effects